- Home
- ORMP vs VERI Comparison
ORMP vs VERI Comparison
Compare ORMP & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORMP | VERI |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.3M | 168.9M |
| IPO Year | 2010 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ORMP | VERI |
|---|---|---|
| Price | $4.66 | $2.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 158.2K | ★ 2.5M |
| Earning Date | 05-14-2026 | 04-15-2026 |
| Dividend Yield | ★ 6.51% | N/A |
| EPS Growth | ★ 412.50 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | $2,000,000.00 | ★ $92,637,000.00 |
| Revenue This Year | N/A | $52.20 |
| Revenue Next Year | N/A | $3.06 |
| P/E Ratio | $3.13 | ★ N/A |
| Revenue Growth | ★ 49.25 | N/A |
| 52 Week Low | $1.98 | $1.29 |
| 52 Week High | $5.01 | $9.42 |
Technical Indicators
Market Signals| Indicator | ORMP | VERI |
|---|---|---|
| Relative Strength Index (RSI) | 69.57 | 45.72 |
| Support Level | $3.21 | $2.02 |
| Resistance Level | N/A | $2.46 |
| Average True Range (ATR) | 0.22 | 0.15 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 68.64 | 38.38 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.